Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CritiTech and AAIPharma Services Announce Strategic Alliance

Abstract:
Alliance to Provide A Novel Drug Delivery Option to Pharmaceutical and Biotech Companies

CritiTech and AAIPharma Services Announce Strategic Alliance

Lawrence, KS & Willmington, NC | Posted on July 10th, 2010

AAIPharma Services Corp., a biopharmaceutical drug product development and contract manufacturing company, and CritiTech, Inc., a nanotechnology company that improves the delivery of therapeutic molecules, announce a strategic alliance to expand the reach of the CritiTech technology.

This alliance will allow pharmaceutical and biotech companies to choose a novel drug delivery option in early animal toxicology and clinical studies where there is a drug delivery challenge that cannot be solved through conventional approaches. Drug product development and manufacturing will be performed by AAIPharma Services, and drug product intermediate manufacturing will be performed by CritiTech. The two companies will be connected through AAIPharma Services' best-in-class project management expertise.

AAIPharma Services Corp already offers both its own proprietary drug delivery technologies as well as other technologies through its alliance partners, such as Emisphere Inc. The alliance with CritiTech provides a new drug delivery option for parenteral administration to complement AAIPharma Services already established oral drug delivery franchise. CritiTech's technology aims to improve the delivery of therapeutic molecules with low aqueous solubility or poor bioavailability. The key benefit of the CritiTech technology is the body's improved ability to absorb these difficult to formulate drugs. One key differentiator of the Crititech technology is it allows for parenteral administration of drugs which previously could not be administered via this route.

Chief Executive Officer of CritiTech Inc. David Johnston said "The Alliance with AAI Pharma services allows us to share the established CritiTech technology, used in our Nanotax™ product currently in development, with a broad range of potential customers. The collaboration with AAI Pharma services and their outstanding product development and manufacturing capability allows us to provide additional drug delivery options throughout the drug product development cycle and to more fully exploit CritiTech technology."

Chief Executive Officer of AAIPharma's Services L. Lee Karras added, "The alliance with CritiTech allows us to add a breakthrough drug delivery option for our pharmaceutical and biotech customers, whether they are developing a new product or improving an existing product already on the market. The combination of the CritiTech technology and AAIPharma Service's best- in- class drug product development and contract manufacturing services will be of tremendous value to customers. This new offering is in line with our strategy to become the leading provider of complex drug development services to the pharmaceutical and biotechnology industries."

####

About AAIPharma Services
AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America. It is headquartered in Wilmington, North Carolina. For more information on the company, go to www.aaipharma.com.

About CritiTech Technologies, Inc.
CritiTech is a technology company that focuses on a unique and improved delivery of therapeutic molecules and compounds using its patented nanotechnology. CritiTech’s technology is licensed from the Department of Chemical Engineering at the University of Kansas and the Higuchi Biosciences Center. The technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, vaginal or transdermal. CritiTech laboratory operations are located in Lawrence, Kansas. For more information on the company, go to www.crititech.com.

For more information, please click here

Contacts:
Media contacts:
AAIPharma Services .
Barry Johnson
800.575.4224, 919.260.6696


CritiTech Technologies, Inc
Davd Johnston Ph.D.
910.508.7994

Copyright © AAIPharma Services

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Leti and Taiwanese Tech Organizations Sponsoring Workshop in Taipei on MEMS, IoT, Smart Lighting Applications, System Reliability & Security September 28th, 2016

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Nanomedicine

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016

BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays September 20th, 2016

Announcements

Leti and Taiwanese Tech Organizations Sponsoring Workshop in Taipei on MEMS, IoT, Smart Lighting Applications, System Reliability & Security September 28th, 2016

Oxford Instruments systems now facilitate water purification technology September 27th, 2016

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Nanobiotechnology

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016

BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays September 20th, 2016

Alliances/Trade associations/Partnerships/Distributorships

PHENOMEN is a FET-Open Research Project aiming to lay the foundations a new information technology September 19th, 2016

SEMI and MSIG Join Together in Strategic Association Partnership: MEMS & Sensors Industry Group Brings New MEMS and Sensors Community to SEMI to Increase Combined Member Value September 15th, 2016

Leti and Oberthur Technologies Partner to Explore New Solutions in Fast-growing Digital Era September 12th, 2016

Synopsys Joins GLOBALFOUNDRIES’ FDXcelerator Partner Program to Enable Innovative Designs Using the FD-SOI Process: Program Gives Synopsys Access to GLOBALFOUNDRIES’ FDX Portfolio and Provides Customers with Tools that Support the Differentiated Features of FD-SOI September 8th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic